Osage Partners

Osage Venture Partners has promoted Sean Dowling to partner.

Fairfax, Virginia-based MarginEdge, a restaurant software platform, has raised $5 million in Series A funding. Osage Venture Partners led the round with participation from other investors that included In Good Company.

The Pennsylvania venture capital firm closes its third life sciences fund.

Osage University Partners has closed its third fund at $273 million, beating its $250 million target. The Bala Cynwyd, Pennsylvania-based venture firm invests in startups that commercialize university research.

DrayNow, a provider of technology-driven solutions for the intermodal freight industry, has raised $5 million in Series A funding. Comcast Ventures led the round with participation from Osage Venture Partners.

An investor syndicate that includes New Enterprise Associates, Frazier Healthcare Partners, Roche Venture Fund, Innobio managed by Bpifrance, Osage University Partners, Altitude Life Science Ventures, Adams Street Partners, and Longwood Fund has committed to invest $30 million in the newly merged OvaScienceSM and Millendo Therapeutics. OvaScience is a developer of treatments for women and couples struggling with infertility while Millendo Therapeutics Inc is a clinical-stage biopharmaceutical company focused on treating orphan endocrine diseases. The newly combined company is expected to operate under the name Millendo Therapeutics and trade on the NASDAQ under the ticker symbol "MLND."

StreetLight Data said it raised $10 million of Series C capital in an oversubscribed round backed by Osage University Partners, ENGIE New Ventures, Deutsche Telekom Capital Partners and others.

Osage University Partners is seeking to raise $250 million for its third fund, according to an SEC filing. https://www.sec.gov/Archives/edgar/data/1743036/000174303618000003/xslFormDX01/primary_doc.xml The Bala Cynwyd, Pennsylvania-based venture firm invests in startups that commercialize university research.

Both appointments were effective January 1, 2023.

US Venture Partners led the round.

Brimstone has raised $55 million in Series A funding.

Circonus, a full-stack monitoring and analytics platform built for the modern-day enterprise, has secured $10 million in Series B funding.

Corelight, a provider of a network detection and response platform, has raised $75 million in Series D funding.

New York-based ExecOnline, a provider of online leadership development for enterprises, has secured $45 million in a Series D financing.

eGenesis, a gene-editing and genome-engineering company, has closed $125 million in Series C financing.

Vor Biopharma, a cell therapy company, has raised about $176.9 million for its IPO after pricing its over 9.8 million shares at $18 per share.